|
Volumn 19, Issue 2, 2001, Pages 407-411
|
Soluble low-molecular-mass tumor-associated proteins promote the suppression of mammary tumors by cyclophosphamide.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
7,12 DIMETHYLBENZ[A]ANTHRACENE;
ALKYLATING AGENT;
CYCLOPHOSPHAMIDE;
TUMOR PROTEIN;
ANIMAL;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
CHEMISTRY;
DRUG COMBINATION;
DRUG POTENTIATION;
EXPERIMENTAL NEOPLASM;
HUMAN;
MOLECULAR WEIGHT;
PATHOLOGY;
RAT;
SOLUBILITY;
TIME;
TREATMENT OUTCOME;
9,10-DIMETHYL-1,2-BENZANTHRACENE;
ANIMALS;
ANTINEOPLASTIC AGENTS, ALKYLATING;
CYCLOPHOSPHAMIDE;
DRUG SYNERGISM;
DRUG THERAPY, COMBINATION;
HUMANS;
MAMMARY NEOPLASMS, EXPERIMENTAL;
MOLECULAR WEIGHT;
NEOPLASM PROTEINS;
RATS;
SOLUBILITY;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 0035432747
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: 10.3892/ijo.19.2.407 Document Type: Article |
Times cited : (6)
|
References (0)
|